Evaluation of early results of cardiac surgery with Normacor under cardiopulmonary bypass
Purpose of the study
Evaluation of early results of cardiac surgery using the cardioplegic solution Normacor under cardiopulmonary bypass.
After coronary artery reperfusion, rhythm was restored spontaneously in most patients
Sinus rhythm was restored spontaneously in 24 patients (54.5%), the original atrial fibrillation rhythm in 6 patients (13.6%); in 12 patients (27%) - after a single defibrillation, 2 patients (5%) required temporary pacemaker.
- 54,5%Sinus rhythm
- 27%After defibrillation
- 13,6%Initial atrial fibrillation
- 5%Temporary pacing
Half of the patients retained atrial activity during surgery
In 22 (50%) patients, atrial activity was maintained during surgery without adverse effects.
- 50%yes
- 50.00%no
Types of operations performed with Normacor
Isolated CABG — 32 (72.7%) patients, heart valve replacement (HVR) — 8 patients (18.2%), 2 patients (4.5%) — aneurysm resection and LV plastic surgery, 2 patients (4.5%) — CABG and HVR.
- 72,7%CABG
- 18,2%HVR
- 4,5%Aneurysm resection and LV plastic surgery
- 4,5%CABG and HVR
All patients were discharged from the hospital without any signs of heart failure
All 44 patients (100%) were discharged from the hospital in satisfactory condition, without signs of heart failure.
- 100%yes
- 0.00%no
Conclusion
The obtained results demonstrate the efficacy and safety of the cardioplegic solution "Normacor" in patients undergoing surgical treatment on a plegic heart under conditions of cardiopulmonary bypass.
Atrial activity under conditions of cardiac protection with Normacor cardioplegia did not cause negative effects.
